Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1228228

Cover Image

PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1228228

Insulin Pump Market - Global Outlook and Forecast 2023-2028

PUBLISHED:
PAGES: 279 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4200
PDF (5 User License)
USD 4999
PDF (Corporate User License)
USD 5999

Add to Cart

The global insulin pump market size is expected to grow at a CAGR of 8.46% 2022-2028

MARKET DRIVERS & OPPORTUNITIES

Technological Advancements Are Revolutionizing the Insulin Delivery

The insulin pump market is constantly evolving with new features with technological advancements like the launch of smarter insulin pumps and more connected devices. Most industry players, such as Medtronic, Tandem Diabetes Care, Insulet Corporation, and others, are continuously evolving in technology advancement and new product deliveries in recent years.

The explosion in research and development and published studies about the closed-loop system with insulin pumps in diabetes management gives new insulin pump market growth opportunities. Several hybrid systems are expected to be commercialized in the future associated with insulin delivery. In addition to those already available in the market, various systems are expected to be launched. For instance, DBLG1 (Diabeloop, Grenoble, France) received the CE market in European countries for its application in the type 1 diabetes adult patient population. Products like insulin-only iLEt (Beta Bionics, the US) and Omnipod Horizon (Insulet, Billerica, the US) are under clinical trials and are expected to reach the industry in the future.

Increasing Diabetes Prevalence & Expenditure

Under the overall diabetes population, type 1 diabetes patients are highly dependent on the external support of insulin delivery. These major patient populations significantly propel the insulin pump market growth. In 2021, the estimated prevalence of diabetes among adults 20 - 79 years old increased more than three times, from an estimated 151 million (approximately 4.6% of the global population at the time of 2000) to around 537 million (10.5%) in 2021. Based on that, by 2030, around 643 million population expected to increase. And if the prevalence rate remains the same, it is expected to jump to around 783 million (12.2%) by 2045.

Government Initiatives for Diabetes Care Management

Rising government initiatives for diabetes care management highly drive insulin pump market growth. Responding to the increasing burden of diabetes worldwide delivers a high demand for care. It positively influenced government initiatives and funding from public and private entities to improve global, regional, and national diabetes health improvements. Based on that, several government and health authorities are making efforts for diabetes care access to comprehensive, equitable, affordable, quality care and medical and technology-based treatments.

Available Reimbursement Policies and Healthcare Insurance for Insulin Pump

The cost of an insulin pump and associated insulin solutions is comparatively higher than other insulin delivery solutions due to the advancement and additional features associated with the products. However, the available reimbursement policies and healthcare insurance coverage highly support the adoption of insulin pumps. In most countries, these policies favor patients who reduce the cost burden and accelerate the adoption of insulin pumps. These insurances cover the insulin pump and include the insulin pump consumables. This is one of the positive signs that is driving the insulin pump market at a faster rate.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT

  • The global insulin pump market by product is segmented into the pump and consumables segment, under which insulin pumps is the major category used in diabetes management and account for a significant 65.85% industry share. The insulin pump adoption for type 1 diabetes patients is constantly increasing, boosting segmental growth. With the increasing diabetes prevalence and a significant burden on health systems, there is an increasing demand for new technologies in diabetes care delivery.
  • The advancement in insulin pumps stands as a golden opportunity for diabetes patients as well as healthcare professionals. It not only gives better clinical outcomes in diabetes management but also increases the confidence of patients and medical professionals in self-medication in diabetes care. It reduces hospital visits and associated cost burden and gives freedom from injections and interventions that take time to heal and deliver care. Insulin pumps are now available worldwide with advanced features that bring several advantages. In addition, the technology advancement, shifting diabetes patients from alternative methods to pumps used for insulin delivery, and the available reimbursement policies are some other factors accelerating the segmental growth.

Segmentation By Products

  • Pump
    • Tethered Pump
    • Patch Pump
  • Consumables

INSIGHTS BY DISEASE

The global insulin pump market by patients is segmented into Type 1 diabetes and Type 2 diabetes. Type 1 diabetes dominated the disease segment and was valued at USD 3.33 billion in 2022. In the type 1 diabetes patient population, an insulin pump plays a vital role, delivering better glycemic control than multiple daily injections. Children are the major targeted population that receives insulin through continuous subcutaneous insulin infusions such as insulin pumps. Also, in the pediatric type 1 diabetes population, insulin pumps showed better glycemic control, which induced a significant demand for insulin pumps. Further, Type 1 diabetes patients are highly dependent on external insulin delivery support due to the loss of insulin production ability. Most of the insulin-dependent type 1 diabetes patients in developed countries accepted the use of insulin pumps over the other alternative methods and contributed to higher market growth.

Segmentation By Disease

  • Type 1 Diabetes
  • Type 2 Diabetes

INSIGHTS BY END-USERS

The hospitals end-user accounted for 51.82% insulin pump market share and dominated the end-user segment. Hospitals are the major contributor to the adoption of insulin pumps. The significant patient population is dependent on hospital settings to manage their diabetes. As the prevalence of diabetes increases every day, the demand and popularity of diabetes management devices are increasing, and insulin pumps are becoming a top priority for medical professionals. The use of insulin pumps has shown tremendous medical outcomes with appropriate insulin delivery in Type 1 & Type 2 diabetes patients. People's quality of life is improving over the traditional and alternative methods. Such factors increase high insulin pump consumption in hospital settings and contribute to significant segmental growth.

Segmentation By End-Users

  • Hospital
  • Home Healthcare Settings
  • Others

GEOGRAPHICAL ANALYSIS

  • North America dominates the global insulin pump market with the higher use of insulin pumps in various demographics suffering from diabetes. The substantial diabetes management burden and higher expenditure in the region accelerate the highest insulin pump adoption. One in three Type 1 diabetes patient population uses insulin pumps in the US only, accounting for more than 30% of Type 1 diabetes patients using insulin pumps in the country. In terms of research and development, advancement in insulin pumps, higher expenditure on diabetes care and management, and government initiatives are some factors that fuel the industry growth in the region.
  • The insulin pump market in Europe was valued at USD 1.17 billion in 2022. In Europe, domestic and international market players initiated innovative clinical research in insulin pump therapy when the adoption of insulin pumps was limited in the last decades. The increasing prevalence of Type 1 diabetes among European countries is the key factor fueling the acceptance of insulin pumps. Also, the increasing expenditure for diabetes management in Germany, France, the UK, Italy, Spain, and the Netherlands delivers lucrative market growth opportunities.

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa

VENDOR LANDSCAPE

The global insulin pump market is highly concentrated, with a limited number of players. Various innovative products like patch pumps are being introduced into the market, and the adoption rate is comparatively higher. Tandem Diabetes Care is one of the leading companies in the insulin pump market; estimated that around 750,000 people in the U.S. are currently using an insulin pump. Moreover, the company stated that approximately 450,000 people use insulin pumps in more than 20 countries outside the United States. The company's insulin pump is widely available in the global market.

Key Company Profiles

  • Insulet Corporation
  • Medtronic
  • Tandem Diabetes Care

Other Prominent Vendors

  • CeQur Simplicity
  • EOFLOW
  • Debiotech SA
  • F-Hoffmann-La Roche
  • Medzer.com
  • MicroPort Scientific
  • Novo Nordisk A/S
  • SOOIL Developments Co., Ltd.
  • Terumo
  • ViCentra B.V.
  • Ypsomed
  • Mannkind

KEY QUESTION ANSWERED:

  • 1. How big is the global insulin pump market?
  • 2. What is the growth rate of the insulin pump market?
  • 3. Who are the key players in the global insulin pump market?
  • 4. What are the growing trends in the insulin pump market?
  • 5. Which region holds the most significant global insulin pump market share?
Product Code: ARZ230126

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY PRODUCT
    • 4.3.2 MARKET SEGMENTATION BY PATIENT GROUP
    • 4.3.3 MARKET SEGMENTATION BY END-USER
    • 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

  • 6.1 OVERVIEW

7 MARKET AT A GLANCE

8 INTRODUCTION

  • 8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 NEW PRODUCT LAUNCHES AND TECHNOLOGICAL ADVANCES IN DIABETES CARE
  • 9.2 INCREASE IN DEMAND FOR CLOSED-LOOP TECHNOLOGY
  • 9.3 TRANSITION OF PATIENTS FROM MULTIPLE DAILY INJECTIONS TO INSULIN PUMPS

10 MARKET GROWTH ENABLERS

  • 10.1 INCREASE IN PREVALENCE OF DIABETES & EXPENDITURE
  • 10.2 GOVERNMENT INITIATIVES FOR DIABETES CARE MANAGEMENT
  • 10.3 AVAILABLE REIMBURSEMENT POLICIES AND HEALTHCARE INSURANCE FOR INSULIN PUMPS

11 MARKET RESTRAINTS

  • 11.1 HIGH-COST BURDEN OF INSULIN PUMPS
  • 11.2 AVAILABLE ALTERNATIVE SOLUTIONS FOR INSULIN PUMPS
  • 11.3 INCREASE IN UNDIAGNOSED DIABETIC POPULATION

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
    • 12.2.1 INSIGHTS BY PATIENT GROUP
    • 12.2.2 INSIGHTS BY PRODUCT
    • 12.2.3 INSIGHTS BY END-USER
    • 12.2.4 INSIGHTS BY GEOGRAPHY
  • 12.3 FIVE FORCES ANALYSIS
    • 12.3.1 THREAT OF NEW ENTRANTS
    • 12.3.2 BARGAINING POWER OF SUPPLIERS
    • 12.3.3 BARGAINING POWER OF BUYERS
    • 12.3.4 THREAT OF SUBSTITUTES
    • 12.3.5 COMPETITIVE RIVALRY

13 PRODUCT

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 PUMP
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 MARKET BY GEOGRAPHY
  • 13.4 TETHERED PUMP
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 MARKET BY GEOGRAPHY
  • 13.5 PATCH PUMP
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
    • 13.5.3 MARKET BY GEOGRAPHY
  • 13.6 CONSUMABLES
    • 13.6.1 MARKET OVERVIEW
    • 13.6.2 MARKET SIZE & FORECAST
    • 13.6.3 MARKET BY GEOGRAPHY

14 PATIENT GROUP

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 TYPE 1 DIABETES
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MARKET BY GEOGRAPHY
  • 14.4 TYPE 2 DIABETES
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 MARKET BY GEOGRAPHY

15 END-USER

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 HOSPITALS
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
    • 15.3.3 MARKET BY GEOGRAPHY
  • 15.4 HOME HEALTHCARE SETTINGS
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
    • 15.4.3 MARKET BY GEOGRAPHY
  • 15.5 OTHERS
    • 15.5.1 MARKET OVERVIEW
    • 15.5.2 MARKET SIZE & FORECAST
    • 15.5.3 MARKET BY GEOGRAPHY

16 GEOGRAPHY

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 GEOGRAPHIC OVERVIEW

17 NORTH AMERICA

  • 17.1 MARKET OVERVIEW
  • 17.2 MARKET SIZE & FORECAST
  • 17.3 PRODUCT
    • 17.3.1 MARKET SIZE & FORECAST
  • 17.4 PUMP
    • 17.4.1 MARKET SIZE & FORECAST
  • 17.5 PATIENT GROUP
    • 17.5.1 MARKET SIZE & FORECAST
  • 17.6 END-USER
    • 17.6.1 MARKET SIZE & FORECAST
  • 17.7 KEY COUNTRIES
    • 17.7.1 US: MARKET SIZE & FORECAST
    • 17.7.2 CANADA: MARKET SIZE & FORECAST

18 EUROPE

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
  • 18.3 PRODUCT
    • 18.3.1 MARKET SIZE & FORECAST
  • 18.4 PUMP
    • 18.4.1 MARKET SIZE & FORECAST
  • 18.5 PATIENT GROUP
    • 18.5.1 MARKET SIZE & FORECAST
  • 18.6 END-USER
    • 18.6.1 MARKET SIZE & FORECAST
  • 18.7 KEY COUNTRIES
    • 18.7.1 GERMANY: MARKET SIZE & FORECAST
    • 18.7.2 FRANCE: MARKET SIZE & FORECAST
    • 18.7.3 UK: MARKET SIZE & FORECAST
    • 18.7.4 ITALY: MARKET SIZE & FORECAST
    • 18.7.5 SPAIN: MARKET SIZE & FORECAST

19 APAC

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
  • 19.3 PRODUCT
    • 19.3.1 MARKET SIZE & FORECAST
  • 19.4 PUMP
    • 19.4.1 MARKET SIZE & FORECAST
  • 19.5 PATIENT GROUP
    • 19.5.1 MARKET SIZE & FORECAST
  • 19.6 END-USER
    • 19.6.1 MARKET SIZE & FORECAST
  • 19.7 KEY COUNTRIES
    • 19.7.1 CHINA: MARKET SIZE & FORECAST
    • 19.7.2 JAPAN: MARKET SIZE & FORECAST
    • 19.7.3 INDIA: MARKET SIZE & FORECAST
    • 19.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
    • 19.7.5 AUSTRALIA: MARKET SIZE & FORECAST

20 LATIN AMERICA

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
  • 20.3 PRODUCT
    • 20.3.1 MARKET SIZE & FORECAST
  • 20.4 PUMP
    • 20.4.1 MARKET SIZE & FORECAST
  • 20.5 PATIENT GROUP
    • 20.5.1 MARKET SIZE & FORECAST
  • 20.6 END-USER
    • 20.6.1 MARKET SIZE & FORECAST
  • 20.7 KEY COUNTRIES
    • 20.7.1 BRAZIL: MARKET SIZE & FORECAST
    • 20.7.2 MEXICO: MARKET SIZE & FORECAST
    • 20.7.3 ARGENTINA: MARKET SIZE & FORECAST

21 MIDDLE EAST & AFRICA

  • 21.1 MARKET OVERVIEW
  • 21.2 MARKET SIZE & FORECAST
  • 21.3 PRODUCT
    • 21.3.1 MARKET SIZE & FORECAST
  • 21.4 PUMP
    • 21.4.1 MARKET SIZE & FORECAST
  • 21.5 PATIENT GROUP
    • 21.5.1 MARKET SIZE & FORECAST
  • 21.6 END-USER
    • 21.6.1 MARKET SIZE & FORECAST
  • 21.7 KEY COUNTRIES
    • 21.7.1 TURKEY: MARKET SIZE & FORECAST
    • 21.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 21.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST

22 COMPETITIVE LANDSCAPE

  • 22.1 COMPETITION OVERVIEW
  • 22.2 MARKET SHARE ANALYSIS
    • 22.2.1 INSULET CORPORATION
    • 22.2.2 MEDTRONIC
    • 22.2.3 TANDEM DIABETES CARE

23 KEY COMPANY PROFILES

  • 23.1 INSULET CORPORATION
    • 23.1.1 BUSINESS OVERVIEW
    • 23.1.2 PRODUCT OFFERINGS
    • 23.1.3 KEY STRATEGIES
    • 23.1.4 KEY STRENGTHS
    • 23.1.5 KEY OPPORTUNITIES
  • 23.2 MEDTRONIC
    • 23.2.1 BUSINESS OVERVIEW
    • 23.2.2 PRODUCT OFFERINGS
    • 23.2.3 KEY STRATEGIES
    • 23.2.4 KEY STRENGTHS
    • 23.2.5 KEY OPPORTUNITIES
  • 23.3 TANDEM DIABETES CARE
    • 23.3.1 BUSINESS OVERVIEW
    • 23.3.2 PRODUCT OFFERINGS
    • 23.3.3 KEY STRATEGIES
    • 23.3.4 KEY STRENGTHS
    • 23.3.5 KEY OPPORTUNITIES

24 OTHER PROMINENT VENDORS

  • 24.1 CEQUR SIMPLICITY
    • 24.1.1 BUSINESS OVERVIEW
    • 24.1.2 PRODUCT OFFERINGS
  • 24.2 EOFLOW
    • 24.2.1 BUSINESS OVERVIEW
    • 24.2.2 PRODUCT OFFERINGS
  • 24.3 DEBIOTECH SA
    • 24.3.1 BUSINESS OVERVIEW
    • 24.3.2 PRODUCT OFFERINGS
  • 24.4 F-HOFFMANN-LA ROCHE
    • 24.4.1 BUSINESS OVERVIEW
    • 24.4.2 PRODUCT OFFERINGS
  • 24.5 MEDZER.COM
    • 24.5.1 BUSINESS OVERVIEW
    • 24.5.2 PRODUCT OFFERINGS
  • 24.6 MICROPORT SCIENTIFIC
    • 24.6.1 BUSINESS OVERVIEW
    • 24.6.2 PRODUCT OFFERINGS
  • 24.7 NOVO NORDISK A/S
    • 24.7.1 BUSINESS OVERVIEW
    • 24.7.2 PRODUCT OFFERINGS
  • 24.8 SOOIL DEVELOPMENTS CO., LTD.
    • 24.8.1 BUSINESS OVERVIEW
    • 24.8.2 PRODUCT OFFERINGS
  • 24.9 TERUMO
    • 24.9.1 BUSINESS OVERVIEW
    • 24.9.2 PRODUCT OFFERINGS
  • 24.10 VICENTRA B. V.
    • 24.10.1 BUSINESS OVERVIEW
    • 24.10.2 PRODUCT OFFERINGS
  • 24.11 YPSOMED
    • 24.11.1 BUSINESS OVERVIEW
    • 24.11.2 PRODUCT OFFERINGS
  • 24.12 MANNKIND
    • 24.12.1 BUSINESS OVERVIEW
    • 24.12.2 PRODUCT OFFERINGS

25 REPORT SUMMARY

  • 25.1 KEY TAKEAWAYS
  • 25.2 STRATEGIC RECOMMENDATIONS

26 QUANTITATIVE SUMMARY

  • 26.1 MARKET BY GEOGRAPHY
  • 26.2 MARKET BY PRODUCT
  • 26.3 MARKET BY PATIENT GROUP
  • 26.4 MARKET BY END-USER
  • 26.5 PRODUCT: MARKET BY GEOGRAPHY
    • 26.5.1 PUMP: MARKET BY GEOGRAPHY
    • 26.5.2 CONSUMABLES: MARKET BY GEOGRAPHY
    • 26.5.3 TETHERED PUMP: MARKET BY GEOGRAPHY
    • 26.5.4 PATCH PUMP: MARKET BY GEOGRAPHY
  • 26.6 PATIENT GROUP: MARKET BY GEOGRAPHY
    • 26.6.1 TYPE 1 DIABETES: MARKET BY GEOGRAPHY
    • 26.6.2 TYPE 2 DIABETES: MARKET BY GEOGRAPHY
  • 26.7 END-USER: MARKET BY GEOGRAPHY
    • 26.7.1 HOSPITALS: MARKET BY GEOGRAPHY
    • 26.7.2 HOME HEALTHCARE SETTINGS: MARKET BY GEOGRAPHY
    • 26.7.3 OTHERS: MARKET BY GEOGRAPHY

27 APPENDIX

  • 27.1 ABBREVIATIONS
Product Code: ARZ230126

LIST OF EXHIBITS

  • EXHIBIT 1 SEGMENTATION OF GLOBAL INSULIN PUMPS MARKET
  • EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
  • EXHIBIT 3 GLOBAL INSULIN PUMPS MARKET: OPPORTUNITIES, DRIVERS, & RESTRAINTS
  • EXHIBIT 4 GLOBAL INSULIN PUMPS MARKET SEGMENTATION 2022-2028
  • EXHIBIT 5 GLOBAL INCIDENCE NUMBER AND INCIDENCE RATE OF DIABETES 1990-2025
  • EXHIBIT 6 GLOBAL PREVALENCE AND PREVALENCE RATE OF DIABETES 1990-2025
  • EXHIBIT 7 GLOBAL DIABETES ASSOCIATED DEATH AND MORTALITY RATE 1990-2025
  • EXHIBIT 8 GLOBAL DALYS NUMBER AND DALYS RATE OF DIABETES 1990-2025
  • EXHIBIT 9 GLOBAL DIABETES PREVALENCE & ASSOCIATED TARGET PATIENT POPULATION IN 2021 (MILLION)
  • EXHIBIT 10 IMPACT OF NEW PRODUCT LAUNCHES AND TECHNOLOGICAL ADVANCES IN DIABETES CARE
  • EXHIBIT 11 IMPACT OF INCREASE IN DEMAND FOR CLOSED-LOOP TECHNOLOGY
  • EXHIBIT 12 EVOLUTION OF INSULIN PUMP TECHNOLOGY
  • EXHIBIT 13 IMPACT OF TRANSITION OF PATIENTS FROM MULTIPLE DAILY INJECTIONS TO INSULIN PUMPS
  • EXHIBIT 14 SHIFT FROM MDI TO INSULIN PUMPS: BASED ON VENDOR ANALYSIS 2021
  • EXHIBIT 15 IMPACT OF INCREASE IN PREVALENCE OF DIABETES & EXPENDITURE
  • EXHIBIT 16 PEOPLE WITH DIABETES WORLDWIDE & BY IDF REGION 2021-2045 (20-79 YEARS) (MILLION)
  • EXHIBIT 17 IMPACT OF GOVERNMENT INITIATIVES FOR DIABETES CARE MANAGEMENT
  • EXHIBIT 18 IMPACT OF AVAILABLE REIMBURSEMENT POLICIES AND HEALTHCARE INSURANCE FOR INSULIN PUMPS
  • EXHIBIT 19 REIMBURSEMENT STRUCTURE FOR INSULIN PUMPS
  • EXHIBIT 20 IMPACT OF HIGH-COST BURDEN OF INSULIN PUMPS
  • EXHIBIT 21 IMPACT OF AVAILABLE ALTERNATIVE SOLUTIONS FOR INSULIN PUMPS
  • EXHIBIT 22 IMPACT OF ALTERNATIVE SOLUTIONS FOR INSULIN PUMPS
  • EXHIBIT 23 IMPACT OF INCREASE IN UNDIAGNOSED DIABETIC POPULATION
  • EXHIBIT 24 PREVALENCE OF UNDIAGNOSED DIABETIC POPULATION IN KEY COUNTRIES 2020
  • EXHIBIT 25 UNDIAGNOSED POPULATION WITH DIABETES BY ECONOMY IN 2020 (MILLIONS)
  • EXHIBIT 26 GLOBAL INSULIN PUMPS MARKET 2022-2028 ($ MILLION)
  • EXHIBIT 27 GLOBAL INSULIN PUMPS MARKET BY PATIENT GROUP
  • EXHIBIT 28 GLOBAL INSULIN PUMPS MARKET BY PRODUCT
  • EXHIBIT 29 GLOBAL INSULIN PUMPS MARKET BY END-USER
  • EXHIBIT 30 GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY
  • EXHIBIT 31 FIVE FORCES ANALYSIS 2022
  • EXHIBIT 32 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028
  • EXHIBIT 33 GLOBAL INSULIN PUMPS MARKET BY PRODUCT 2022-2028
  • EXHIBIT 34 OVERVIEW OF GLOBAL INSULIN PUMPS MARKET BY PRODUCT
  • EXHIBIT 35 GLOBAL INSULIN PUMPS MARKET BY PRODUCT: INCREMENTAL GROWTH
  • EXHIBIT 36 GLOBAL INSULIN PUMPS MARKET BY PRODUCT: ABSOLUTE GROWTH
  • EXHIBIT 37 GLOBAL INSULIN PUMPS MARKET BY PUMP SEGMENT: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 38 GLOBAL INSULIN PUMPS MARKET BY PUMP SEGMENT 2022-2028 ($ MILLION)
  • EXHIBIT 39 GLOBAL INSULIN PUMPS MARKET BY TETHERED PUMP: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 40 GLOBAL INSULIN PUMPS MARKET BY TETHERED PUMP 2022-2028 ($ MILLION)
  • EXHIBIT 41 GLOBAL INSULIN PUMPS MARKET BY PATCH PUMP: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 42 GLOBAL INSULIN PUMPS MARKET BY PATCH PUMP 2022-2028 ($ MILLION)
  • EXHIBIT 43 GLOBAL INSULIN PUMPS MARKET BY CONSUMABLES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 44 GLOBAL INSULIN PUMPS MARKET BY CONSUMABLES 2022-2028 ($ MILLION)
  • EXHIBIT 45 INCREMENTAL GROWTH BY PATIENT GROUP 2022 & 2028
  • EXHIBIT 46 GLOBAL INSULIN PUMPS MARKET BY PATIENT GROUP 2022-2029
  • EXHIBIT 47 OVERVIEW OF GLOBAL INSULIN PUMPS MARKET BY PATIENT GROUP
  • EXHIBIT 48 GLOBAL INSULIN PUMPS MARKET BY PATIENT GROUP: INCREMENTAL GROWTH
  • EXHIBIT 49 GLOBAL INSULIN PUMPS MARKET BY PATIENT GROUP: ABSOLUTE GROWTH
  • EXHIBIT 50 TYPE 1 DIABETES PREVALENCE IN AGE GROUP 0-19 IN 2021
  • EXHIBIT 51 GLOBAL INSULIN PUMPS MARKET BY TYPE 1 DIABETES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 52 GLOBAL INSULIN PUMPS MARKET BY TYPE 1 DIABETES 2022-2028 ($ MILLION)
  • EXHIBIT 53 GLOBAL INSULIN PUMPS MARKET BY TYPE 2 DIABETES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 54 GLOBAL INSULIN PUMPS MARKET BY TYPE 2 DIABETES 2022-2028 ($ MILLION)
  • EXHIBIT 55 INCREMENTAL GROWTH BY END-USER 2022 & 2028
  • EXHIBIT 56 GLOBAL INSULIN PUMPS MARKET BY END-USER 2022-2028
  • EXHIBIT 57 OVERVIEW OF GLOBAL INSULIN PUMPS MARKET BY END-USER
  • EXHIBIT 58 GLOBAL INSULIN PUMPS MARKET BY END-USER: INCREMENTAL GROWTH
  • EXHIBIT 59 GLOBAL INSULIN PUMPS MARKET BY END-USER: ABSOLUTE GROWTH
  • EXHIBIT 60 GLOBAL INSULIN PUMPS MARKET BY HOSPITALS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 61 GLOBAL INSULIN PUMPS MARKET BY HOSPITALS 2022-2028 ($ MILLION)
  • EXHIBIT 62 PREVALENCE OF CHRONIC CONDITIONS AND EXPONENTIAL IMPACT ON HEALTHCARE COSTS IN US
  • EXHIBIT 63 GLOBAL INSULIN PUMPS MARKET BY HOME HEALTHCARE SETTINGS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 64 GLOBAL INSULIN PUMPS MARKET BY HOME HEALTHCARE SETTINGS 2022-2028 ($ MILLION)
  • EXHIBIT 65 GLOBAL INSULIN PUMPS MARKET BY OTHERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 66 GLOBAL INSULIN PUMPS MARKET BY OTHERS 2022-2028 ($ MILLION)
  • EXHIBIT 67 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
  • EXHIBIT 68 GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028
  • EXHIBIT 69 OVERVIEW OF GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY
  • EXHIBIT 70 GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
  • EXHIBIT 71 GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
  • EXHIBIT 72 NORTH AMERICA DIABETES STATISTICS 2021
  • EXHIBIT 73 INSULIN PUMPS MARKET IN NORTH AMERICA: KEY COUNTRIES ($ MILLION)
  • EXHIBIT 74 INSULIN PUMPS MARKET IN NORTH AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 75 INSULIN PUMPS MARKET IN NORTH AMERICA 2022-2028 ($ MILLION)
  • EXHIBIT 76 INCREMENTAL GROWTH IN NORTH AMERICA 2022 & 2028
  • EXHIBIT 77 US TYPE 1 DIABETES STATISTICS (ESTIMATION & PROJECTED POPULATION STATISTICS, 2020-2021 & 2021-2050)
  • EXHIBIT 78 TYPE 1 DIABETES POPULATION USED INSULIN PUMPS IN US IN 2018 (% SHARE)
  • EXHIBIT 79 ADOPTION OF INSULIN PUMPS IN US 2020-2022
  • EXHIBIT 80 INSULIN PUMPS MARKET IN US 2022-2028 ($ MILLION)
  • EXHIBIT 81 TYPE 1 DIABETES STATISTICS OF CANADA 2021
  • EXHIBIT 82 INSULIN PUMPS MARKET IN CANADA 2022-2028 ($ MILLION)
  • EXHIBIT 83 INSULIN PUMPS MARKET IN EUROPE: KEY COUNTRIES ($ MILLION)
  • EXHIBIT 84 INSULIN PUMPS MARKET IN EUROPE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 85 INSULIN PUMPS MARKET IN EUROPE 2022-2028 ($ MILLION)
  • EXHIBIT 86 INCREMENTAL GROWTH IN EUROPE 2022 & 2028
  • EXHIBIT 87 ESTIMATED & PREDICTED DIABETES MANAGEMENT EXPENDITURE IN GERMANY 2021, 2030, & 2045 ($ BILLION)
  • EXHIBIT 88 INSULIN PUMPS MARKET IN GERMANY 2022-2028 ($ MILLION)
  • EXHIBIT 89 FRANCE DIABETES STATISTICS 2021
  • EXHIBIT 90 INSULIN PUMPS MARKET IN FRANCE 2022-2028 ($ MILLION)
  • EXHIBIT 91 UK TYPE 1 DIABETES PREVALENCE STATISTICS & INSULIN PUMP ACCEPTANCE (2016-2021)
  • EXHIBIT 92 INSULIN PUMPS MARKET IN UK 2022-2028 ($ MILLION)
  • EXHIBIT 93 ACCESS TO DIABETES CARE & DELIVERY CYCLE FOR SUPPLIES & TECHNOLOGIES IN ITALY
  • EXHIBIT 94 INSULIN PUMPS MARKET IN ITALY 2022-2028 ($ MILLION)
  • EXHIBIT 95 INSULIN PUMPS MARKET IN SPAIN 2022-2028 ($ MILLION)
  • EXHIBIT 96 ESTIMATED & PROJECTED DIABETES PREVALENCE IN APAC 2021-2045 (MILLION)
  • EXHIBIT 97 INSULIN PUMPS MARKET IN APAC: KEY COUNTRIES ($ MILLION)
  • EXHIBIT 98 INSULIN PUMPS MARKET IN APAC: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 99 INSULIN PUMPS MARKET IN APAC 2022-2028 ($ MILLION)
  • EXHIBIT 100 INCREMENTAL GROWTH IN APAC 2022 & 2028
  • EXHIBIT 101 DIABETES-RELATED ESTIMATED AND PREDICTED HEALTH EXPENDITURE OF CHINA 2021, 2030, & 2045 ($ BILLION)
  • EXHIBIT 102 INSULIN PUMPS MARKET IN CHINA 2022-2028 ($ MILLION)
  • EXHIBIT 103 INSULIN PUMPS MARKET IN JAPAN 2022-2028 ($ MILLION)
  • EXHIBIT 104 DIABETES-RELATED HEALTH EXPENDITURE ESTIMATION & PREDICTION FROM 2021 TO 2045 ($ MILLION)
  • EXHIBIT 105 INDIA DIABETES STATISTICS 2021-2045
  • EXHIBIT 106 INSULIN PUMPS MARKET IN INDIA 2022-2028 ($ MILLION)
  • EXHIBIT 107 DIABETES PREVALENCE &ASSOCIATED EXPENDITURE 2021-2045
  • EXHIBIT 108 INSULIN PUMPS MARKET IN SOUTH KOREA 2022-2028 ($ MILLION)
  • EXHIBIT 109 PREVALENCE OF DIABETES IN AUSTRALIA 2021
  • EXHIBIT 110 INSULIN PUMPS MARKET IN AUSTRALIA 2022-2028 ($ MILLION)
  • EXHIBIT 111 INSULIN PUMPS MARKET IN LATIN AMERICA: KEY COUNTRIES ($ MILLION)
  • EXHIBIT 112 INSULIN PUMPS MARKET IN LATIN AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 113 INSULIN PUMPS MARKET IN LATIN AMERICA 2022-2028 ($ MILLION)
  • EXHIBIT 114 INCREMENTAL GROWTH IN LATIN AMERICA 2022 & 2028
  • EXHIBIT 115 INSULIN PUMPS MARKET IN BRAZIL 2022-2028 ($ MILLION)
  • EXHIBIT 116 ESTIMATED & PROJECTED DIABETES PREVALENCE IN MEXICO 2021, 2030, & 2045 (MILLION)
  • EXHIBIT 117 DIABETES-RELATED ESTIMATED & PROJECTED EXPENDITURE IN MEXICO 2021, 2030, & 2045 ($ BILLION)
  • EXHIBIT 118 INSULIN PUMPS MARKET IN MEXICO 2022-2028 ($ MILLION)
  • EXHIBIT 119 DIABETES-RELATED HEALTH EXPENDITURE IN ARGENTINA 2021, 2030, & 2045 ($ BILLION)
  • EXHIBIT 120 INSULIN PUMPS MARKET IN ARGENTINA 2022-2028 ($ MILLION)
  • EXHIBIT 121 INSULIN PUMPS MARKET IN MIDDLE EAST & AFRICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 122 PREVALENCE OF DIABETES IN MIDDLE EAST & AFRICA 2021-2045 (MILLION)
  • EXHIBIT 123 INSULIN PUMPS MARKET IN MIDDLE EAST & AFRICA: KEY COUNTRIES ($ MILLION)
  • EXHIBIT 124 INSULIN PUMPS MARKET IN MIDDLE EAST & AFRICA 2022-2028 ($ MILLION)
  • EXHIBIT 125 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2022 & 2028
  • EXHIBIT 126 DIABETES PREVALENCE IN TURKEY AMONG ADULTS OF AGE 20-79 YEARS (MILLION)
  • EXHIBIT 127 DIABETES-RELATED HEALTH EXPENDITURE IN TURKEY 2021, 2030, & 2045 ($ BILLION)
  • EXHIBIT 128 INSULIN PUMPS MARKET IN TURKEY 2022-2028 ($ MILLION)
  • EXHIBIT 129 ESTIMATED AND PROJECTED DIABETES PREVALENCE IN SAUDI ARABIA 2000-2045 (MILLION)
  • EXHIBIT 130 INSULIN PUMPS MARKET IN SAUDI ARABIA 2022-2028 ($ MILLION)
  • EXHIBIT 131 ESTIMATED AND PROJECTED DIABETES PREVALENCE IN SOUTH AFRICA 2000-2045 (MILLION)
  • EXHIBIT 132 DIABETES-RELATED ESTIMATED & PROJECTED HEALTH EXPENDITURE IN SOUTH AFRICA 2021-2045 ($ MILLION)
  • EXHIBIT 133 INSULIN PUMPS MARKET IN SOUTH AFRICA 2022-2028 ($ MILLION)
  • EXHIBIT 134 KEY VENDORS OFFERING INSULIN PUMPS: MARKET DOMINANCE ANALYSIS
  • EXHIBIT 135 KEY VENDORS OFFERING INSULIN PUMPS: CAPABILITIES & EXPERTISE ASSESSMENTS
  • EXHIBIT 136 ANNUAL REVENUE OF INSULET CORPORATION 2019-2021 ($ MILLION)
  • EXHIBIT 137 INSULET CORPORATION: REVENUE OF DIABETES SEGMENT 2019-2021 ($ MILLION)
  • EXHIBIT 138 MEDTRONIC REVENUE 2019-2021 ($ BILLION)
  • EXHIBIT 139 TANDEM DIABETES CARE REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 140 TANDEM DIABETES CARE REVENUE 2019-2021 ($ MILLION)

LIST OF TABLES

  • TABLE 1 KEY CAVEATS
  • TABLE 2 CURRENCY CONVERSION 2015-2022
  • TABLE 3 DIABETES PREVALENCE BY WORLD BANK INCOME CLASSIFICATION (ESTIMATION AND PREDICTION) 2021-2045
  • TABLE 4 ADULTS (20-79 YEARS) WITH UNDIAGNOSED DIABETES BY WORLD BANK INCOME CLASSIFICATION IN 2021
  • TABLE 5 PRESENCE OF LARGE POOL OF UNDIAGNOSED POPULATION
  • TABLE 6 PRICING OF INSULIN PUMPS
  • TABLE 7 GLOBAL INSULIN PUMP MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 8 GLOBAL INSULIN PUMP MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 9 GLOBAL TETHERED INSULIN PUMP MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 10 GLOBAL TETHERED INSULIN PUMP MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 11 SOME PATCH PUMPS BY MARKET PLAYERS
  • TABLE 12 GLOBAL PATCH INSULIN PUMP MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 13 GLOBAL PATCH INSULIN PUMP MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 14 GLOBAL INSULIN PUMPS CONSUMABLES MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 15 GLOBAL INSULIN PUMPS CONSUMABLES MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 16 TYPE OF DIABETES & ASSOCIATED MARKET OPPORTUNITIES
  • TABLE 17 GLOBAL TYPE 1 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 18 GLOBAL TYPE 1 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 19 INSULIN PUMPS DESIGNED SPECIFICALLY FOR TYPE 2 DIABETIC PATIENTS
  • TABLE 20 GLOBAL TYPE 2 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 21 GLOBAL TYPE 2 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 22 GLOBAL HOSPITALS INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 23 GLOBAL HOSPITALS INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 24 GLOBAL HOME HEALTHCARE SETTINGS INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 25 GLOBAL HOME HEALTHCARE SETTINGS INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 26 GLOBAL OTHERS INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 27 GLOBAL OTHERS INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 28 NORTH AMERICA INSULIN PUMPS MARKET BY PRODUCT 2022-2028 ($ MILLION)
  • TABLE 29 NORTH AMERICA INSULIN PUMPS MARKET BY PRODUCT 2022-2028 (%)
  • TABLE 30 NORTH AMERICA INSULIN PUMPS MARKET BY PUMP 2022-2028 ($ MILLION)
  • TABLE 31 NORTH AMERICA INSULIN PUMPS MARKET BY PUMP 2022-2028 (%)
  • TABLE 32 NORTH AMERICA INSULIN PUMPS MARKET BY PATIENT GROUP 2022-2028 ($ MILLION)
  • TABLE 33 NORTH AMERICA INSULIN PUMPS MARKET BY PATIENT GROUP 2022-2028 (%)
  • TABLE 34 NORTH AMERICA INSULIN PUMPS MARKET BY END-USER 2022-2028 ($ MILLION)
  • TABLE 35 NORTH AMERICA INSULIN PUMPS MARKET BY END-USER 2022-2028 (%)
  • TABLE 36 EUROPE INSULIN PUMPS MARKET BY PRODUCT 2022-2028 ($ MILLION)
  • TABLE 37 EUROPE INSULIN PUMPS MARKET BY PRODUCT 2022-2028 (%)
  • TABLE 38 EUROPE INSULIN PUMPS MARKET BY PUMP 2022-2028 ($ MILLION)
  • TABLE 39 EUROPE INSULIN PUMPS MARKET BY PUMP 2022-2028 (%)
  • TABLE 40 EUROPE INSULIN PUMPS MARKET BY PATIENT GROUP 2022-2028 ($ MILLION)
  • TABLE 41 EUROPE INSULIN PUMPS MARKET BY PATIENT GROUP 2022-2028 (%)
  • TABLE 42 EUROPE INSULIN PUMPS MARKET BY END-USER 2022-2028 ($ MILLION)
  • TABLE 43 EUROPE INSULIN PUMPS MARKET BY END-USER 2022-2028 (%)
  • TABLE 44 DIABETES-RELATED HEALTH EXPENDITURE 2021-2045 ($ MILLION)
  • TABLE 45 APAC INSULIN PUMPS MARKET BY PRODUCT 2022-2028 ($ MILLION)
  • TABLE 46 APAC INSULIN PUMPS MARKET BY PRODUCT 2022-2028 (%)
  • TABLE 47 APAC INSULIN PUMPS MARKET BY PUMP 2022-2028 ($ MILLION)
  • TABLE 48 APAC INSULIN PUMPS MARKET BY PUMP 2022-2028 (%)
  • TABLE 49 APAC INSULIN PUMPS MARKET BY PATIENT GROUP 2022-2028 ($ MILLION)
  • TABLE 50 APAC INSULIN PUMPS MARKET BY PATIENT GROUP 2022-2028 (%)
  • TABLE 51 APAC INSULIN PUMPS MARKET BY END-USER 2022-2028 ($ MILLION)
  • TABLE 52 APAC INSULIN PUMPS MARKET BY END-USER 2022-2028 (%)
  • TABLE 53 DIABETIC PATIENT POPULATION STATISTICS IN CHINA
  • TABLE 54 LATIN AMERICA INSULIN PUMPS MARKET BY PRODUCT 2022-2028 ($ MILLION)
  • TABLE 55 LATIN AMERICA INSULIN PUMPS MARKET BY PRODUCT 2022-2028 (%)
  • TABLE 56 LATIN AMERICA INSULIN PUMPS MARKET BY PUMP 2022-2028 ($ MILLION)
  • TABLE 57 LATIN AMERICA INSULIN PUMPS MARKET BY PUMP 2022-2028 (%)
  • TABLE 58 LATIN AMERICA INSULIN PUMPS MARKET BY PATIENT GROUP 2022-2028 ($ MILLION)
  • TABLE 59 LATIN AMERICA INSULIN PUMPS MARKET BY PATIENT GROUP 2022-2028 (%)
  • TABLE 60 LATIN AMERICA INSULIN PUMPS MARKET BY END-USER 2022-2028 ($ MILLION)
  • TABLE 61 LATIN AMERICA INSULIN PUMPS MARKET BY END-USER 2022-2028 (%)
  • TABLE 62 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY PRODUCT 2022-2028 ($ MILLION)
  • TABLE 63 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY PRODUCT 2022-2028 (%)
  • TABLE 64 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY PUMP 2022-2028 ($ MILLION)
  • TABLE 65 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY PUMP 2022-2028 (%)
  • TABLE 66 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY PATIENT GROUP 2022-2028 ($ MILLION)
  • TABLE 67 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY PATIENT GROUP 2022-2028 (%)
  • TABLE 68 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY END-USER 2022-2028 ($ MILLION)
  • TABLE 69 MIDDLE EAST & AFRICA INSULIN PUMPS MARKET BY END-USER 2022-2028 (%)
  • TABLE 70 INSULET CORPORATION: MAJOR PRODUCT OFFERINGS
  • TABLE 71 MEDTRONIC: MAJOR PRODUCT OFFERINGS
  • TABLE 72 TANDEM DIABETES CARE: MAJOR PRODUCT OFFERINGS
  • TABLE 73 CEQUR SIMPLICITY: MAJOR PRODUCT OFFERINGS
  • TABLE 74 EOFLOW: MAJOR PRODUCT OFFERINGS
  • TABLE 75 DEBIOTECH SA: MAJOR PRODUCT OFFERINGS
  • TABLE 76 F-HOFFMANN-LA ROCHE: MAJOR PRODUCT OFFERINGS
  • TABLE 77 MEDZER.COM: MAJOR PRODUCT OFFERINGS
  • TABLE 78 MICROPORT SCIENTIFIC: MAJOR PRODUCT OFFERINGS
  • TABLE 79 NOVO NORDISK A/S: MAJOR PRODUCT OFFERINGS
  • TABLE 80 SOOIL DEVELOPMENTS CO., LTD.: MAJOR PRODUCT OFFERINGS
  • TABLE 81 TERUMO: MAJOR PRODUCT OFFERINGS
  • TABLE 82 VICENTRA B.V.: MAJOR PRODUCT OFFERINGS
  • TABLE 83 YPSOMED: MAJOR PRODUCT OFFERINGS
  • TABLE 84 MANNKIND: MAJOR PRODUCT OFFERINGS
  • TABLE 85 GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 86 GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 87 GLOBAL INSULIN PUMPS MARKET BY PRODUCT 2022-2028 ($ MILLION)
  • TABLE 88 GLOBAL INSULIN PUMPS MARKET BY PRODUCT 2022-2028 (%)
  • TABLE 89 GLOBAL INSULIN PUMPS MARKET BY PATIENT GROUP 2022-2028 ($ MILLION)
  • TABLE 90 GLOBAL INSULIN PUMPS MARKET BY PATIENT GROUP 2022-2028 (%)
  • TABLE 91 GLOBAL INSULIN PUMPS MARKET BY END-USER 2022-2028 ($ MILLION)
  • TABLE 92 GLOBAL INSULIN PUMPS MARKET BY END-USER 2022-2028 (%)
  • TABLE 93 GLOBAL INSULIN PUMP MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 94 GLOBAL INSULIN PUMP MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 95 GLOBAL CONSUMABLES INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 96 GLOBAL CONSUMABLES INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 97 GLOBAL TETHERED INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 98 GLOBAL TETHERED INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 99 GLOBAL PATCH INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 100 GLOBAL PATCH INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 101 GLOBAL TYPE 1 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 102 GLOBAL TYPE 1 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 103 GLOBAL TYPE 2 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 104 GLOBAL TYPE 2 DIABETES INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 105 GLOBAL HOSPITALS INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 106 GLOBAL HOSPITALS INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 107 GLOBAL HOME HEALTHCARE SETTINGS INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 108 GLOBAL HOME HEALTHCARE SETTINGS INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 (%)
  • TABLE 109 GLOBAL OTHERS INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
  • TABLE 110 GLOBAL OTHERS INSULIN PUMPS MARKET BY GEOGRAPHY 2022-2028 (%)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!